# Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions

> **NCT01809028** · NA · COMPLETED · sponsor: **AdventHealth** · enrollment: 62 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **PROCEDURE:** EUS FNA with 2 passes
- **PROCEDURE:** EUS FNA with 4 passes

## Key facts

- **NCT ID:** NCT01809028
- **Lead sponsor:** AdventHealth
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2017-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01809028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01809028, "Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01809028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*